How Much Did Remedy Raise?
Funding & Key Investors

Remedy, a dermatologist-founded skincare brand focused on accessible, evidence-based solutions, has secured $20M in total capital. The company recently announced a major strategic investment of $20M, signaling a significant phase of growth and market expansion. This latest financing round underscores the increasing investor confidence in Remedy's science-backed approach to skincare.

What is Remedy?

Remedy
ManufacturingChemicals & Related Products

Remedy was established by dermatologist Dr. Muneeb Shah with the mission to simplify skin health through science. The brand develops advanced treatments that integrate multiple clinically proven ingredients into user-friendly, all-in-one formulations. These products are engineered to target prevalent skin concerns such as hyperpigmentation, aging, enlarged pores, and textural irregularities, all while prioritizing minimal irritation. Remedy's commitment to evidence-based efficacy positions it as a distinctive player in the competitive beauty and wellness sector.

How much funding has Remedy raised?

Remedy has raised a total of $20M across 1 funding round:

2026

Series A

$20M

Series A (2026): $20M with participation from Norwest, Sonoma Brands, and L Catterton

Key Investors in Remedy

Norwest

Norwest is a global venture and growth equity investment firm with over $15.5 billion in capital, dedicated to helping CEOs and founders scale their businesses across various sectors, including biotech, fintech, and consumer products.

Sonoma Brands

Sonoma Brands Capital is a private equity firm that focuses on the growth sectors of the consumer economy, partnering with innovative founders to build enduring brands, particularly in food and beverage, beauty, personal care, and wellness.

L Catterton

L Catterton is a global consumer-focused private equity firm that has made over 275 investments in consumer brands worldwide, deploying capital through various strategies including buyout and growth equity.

What's next for Remedy?

The recent major strategic investment in Remedy suggests a pivotal moment for the company, likely enabling accelerated product development, expanded market reach, and enhanced marketing initiatives. This infusion of capital, part of a significant enterprise-level funding effort, indicates a strategic focus on scaling operations and solidifying its position as a leader in science-driven skincare. Future developments may include new product line introductions, broader retail distribution, and further research into innovative dermatological solutions.

See full Remedy company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingMotor VehiclesRetailAutomobile Parts Stores
Industrial Machinery & EquipmentManufacturing
ManufacturingTest & Measurement EquipmentArchitecture, Engineering & DesignConstructionIndustrial Machinery & EquipmentConstruction Management
Industrial Machinery & EquipmentManufacturing

Frequently Asked Questions Regarding Remedy Financial Insights

What are the most recent funding rounds that Remedy has completed, and what were the funding rounds?
Remedy has recently completed 1 funding rounds: Series A on Jun 10, 2026.
What is the total amount of funding Remedy has raised to date?
Remedy has raised a total of $20M in funding to date.
How many funding rounds has Remedy completed?
Remedy has completed 1 funding rounds.
How much funding did Remedy raise in its most recent funding round?
Remedy raised $20M in its most recent funding round.
Who are the lead investors in Remedy's latest funding round?
The lead investor in Remedy's latest funding round was Norwest. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Remedy's history?
The largest funding round in Remedy's history was $20M.
See more information about Remedy